Log In
Print
BCIQ
Print
Print this Print this
 

FR104

Also known as: Anti-CD28 antibody fragments

  Manage Alerts
Collapse Summary General Information
Company Effimune S.A.S.
DescriptionPegylated monovalent antibody fragment antagonist of CD28 receptor
Molecular Target CD28 receptor
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today